Details of Protein
General Information of Protein (ID: PRT00778) | |||||
---|---|---|---|---|---|
Name | Solute carrier family 7 member 9 (SLC7A9) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
b(0,+)AT1; Glycoprotein-associated amino acid transporter b0,+AT1; b(0,+)-type amino acid transporter 1; SLC7A9; BAT1
|
||||
Gene Name | SLC7A9 | Gene ID | |||
UniProt ID | |||||
Family | Amino acid/polyamine transporter (AAPT) | ||||
TC Number | TC: 2.A.3.8.19 (Click to Show/Hide the Complete TC Tree) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTE
AVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVI KPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIF TAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNY ITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYP ASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGI IATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLI SVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVV PPEEDPE |
||||
Structure | |||||
Function | Involved in the high-affinity, sodium-independent transport of cystine and neutral and dibasic amino acids (system b(0,+)-like activity). Thought to be responsible for the high-affinity reabsorption of cystine in the kidney tubule. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Organic acids and derivatives | ||||||
Cystine | Click to Show/Hide the Full List of Regulating Pair(s): 8 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation ( N227D) of SLC7A9 | |||||
Induced Change | Cystine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
Details | It is reported that mutation ( N227D) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (1105delA; W69stop) of SLC7A9 | |||||
Induced Change | Cystine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
Details | It is reported that mutation (1105delA; W69stop) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
Regulating Pair (3) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (G195R) of SLC7A9 | |||||
Induced Change | Cystine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
Details | It is reported that mutation (G195R) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
Regulating Pair (4) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (L223M) of SLC7A9 | |||||
Induced Change | Cystine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
Details | It is reported that mutation (L223M) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
Regulating Pair (5) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (P482L) of SLC7A9 | |||||
Induced Change | Cystine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
Details | It is reported that mutation (P482L) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
Regulating Pair (6) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (R333Q) of SLC7A9 | |||||
Induced Change | Cystine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
Details | It is reported that mutation (R333Q) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
Regulating Pair (7) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (R333W) of SLC7A9 | |||||
Induced Change | Cystine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
Details | It is reported that mutation (R333W) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
Regulating Pair (8) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (V142A; L223M) of SLC7A9 | |||||
Induced Change | Cystine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Nephropathic cystinosis [ICD-11: 5C60] | |||||
Details | It is reported that mutation (V142A and L223M) of SLC7A9 leads to the decrease of cystine levels compared with control group. | |||||
References | |||||
---|---|---|---|---|---|
1 | A novel missense mutation of SLC7A9 frequent in Japanese cystinuria cases affecting the C-terminus of the transporter. Kidney Int. 2006 Apr;69(7):1198-206. |
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.